TRIBUTES have begun to pour in after the untimely death of ex-Galway All-Star Michael Coleman in an accident at his home. The ...

SAEM Vendée, the company responsible for processing cookies, uses cookies on its website to measure audience and visitor ...

The resulting younger, largely inexperienced teams had been ravaged by Cork in the first round and comfortably held off in Thurles a week ago. Making bad worse were the early injuries to Simon Donohoe ...

Egypt is expanding its Universal Health Insurance System to ensure that all citizens have health coverage by 2030 ...

Violette Dorange completed her first Vendée Globe at 10:39hrs (UTC) today, after 90 days, 22 hrs, 37 min at sea, to not only ...

Roche Holding AG’s US unit removed diversity and inclusion targets from its website, the latest in a series of publicly ...

Pfizer terminated partnership with Sangamo on hemophilia A gene therapy despite positive Phase 3 data. Find out why SGMO ...

1 Day RHHBY 2.56% DJIA 0.77% S&P 500 1.04% Health Care/Life Sciences 0.10% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...